J. Aman (Amsterdam, Netherlands), C. Belge (Leuven, Belgium), H. Bogaard (Amsterdam, Netherlands), S. Ulrich (Zurich, Switzerland)
Late Breaking Abstract - Effects of preventive exercise in monocrotaline rat model with pulmonary hypertension
F. Pacagnelli (Presidente Prudente, Brazil), T. Mariano (Presidente Prudente, Brazil), A. Sabela (Presidente Prudente, Brazil), R. Dias (Presidente Prudente, Brazil), A. Freire (Presidente Prudente, Brazil), L. Junior (Botucatu, Brazil), L. Schaffer (Presidente Prudente, Brazil), R. Carvalho (Botucatu, Brazil), K. Okoshi (Botucatu, Brazil)
|   |
Late Breaking Abstract - The effect of exercise rehabilitation on cardiac function, measured by cardiac MRI, in patients with pre-capillary pulmonary hypertension.
M. McGettrick (Glasgow, United Kingdom), G. Jayasekera (Glasgow, United Kingdom), M. Brewis (Glasgow, United Kingdom), C. Church (Glasgow, United Kingdom), M. Johnson (Glasgow, United Kingdom), A. Mackenzie (Glasgow, United Kingdom)
| |
Late Breaking Abstract - Supplementation of iron in pulmonary hypertension (SIPHON): results from a randomised controlled crossover trial
L. Howard (London, United Kingdom), J. He (Beijing, China), J. Wharton (London, United Kingdom), G. Watson (London, United Kingdom), H. Gall (Giessen, Germany), H. Ghofrani (Giessen, Germany), L. Huang (Beijing, China), D. Kiely (Sheffield, United Kingdom), Q. Luo (Beijing, China), K. Sheares (Cambridge, United Kingdom), L. Zhao (London, United Kingdom), M. Wilkins (London, United Kingdom)
| |
Late Breaking Abstract - Morphine for dyspnea in advanced pulmonary arterial hypertension
D. Christiansen (Winnipeg, Canada), K. Wentlandt (Toronto, Canada), J. Lew (Toronto, Canada), J. Granton (Toronto, Canada)
| |
Late Breaking Abstract - Inflammation and metabolic syndrome exacerbate pulmonary hypertension associated with left heart disease.
B. Ranchoux (Quebec, Canada), V. Nadeau (Quebec, Canada), S. Breuils-Bonnet (Quebec, Canada), J. Omura (Quebec, Canada), M. André (Quebec, Canada), J. Dupuis (Montreal, Canada), P. Pibarot (Quebec, Canada), R. Paulin (Quebec, Canada), O. Boucherat (Quebec, Canada), S. Provencher (Quebec, Canada), S. Archer (Quebec, Canada), S. Bonnet (Quebec, Canada), F. Potus (Kingston, Canada)
| |
Late Breaking Abstract - The effect of altering gut microbiota on the development of pulmonary hypertension
T. Jujo (Chiba, Japan), N. Tanabe (Narashino, Japan), K. Hosomi (Osaka, Japan), H. Shoji (Chiba, Japan), J. Park (Osaka, Japan), Y. Ikubo (Chiba, Japan), A. Yanagisawa (Chiba, Japan), T. Kobayashi (Chiba, Japan), K. Yamamoto (Chiba, Japan), H. Miwa (Chiba, Japan), A. Naito (Chiba, Japan), H. Kasai (Chiba, Japan), R. Suda (Chiba, Japan), A. Sekine (Chiba, Japan), R. Nishimura (Chiba, Japan), T. Sugiura (Chiba, Japan), A. Shigeta (Chiba, Japan), S. Sakao (Chiba, Japan), K. Mizuguchi (Osaka, Japan), J. Kunisawa (Osaka, Japan), K. Tatsumi (Chiba, Japan)
| |
Late Breaking Abstract - Screening of pulmonary arterial hypertension in asymptomatic BMPR2 mutation carriers (DELPHI-2 Study)
D. Montani (le Kremlin Bicêtre, France), B. Girerd (le Kremlin Bicêtre, France), X. Jais (le Kremlin Bicêtre, France), L. Savale (le Kremlin Bicêtre, France), P. Laveneziana (Paris, France), A. Bouchachi (le Kremlin Bicêtre, France), S. Hascoet (le Plessis Robinson, France), S. Gunther (le Kremlin Bicêtre, France), L. Godinas (le Kremlin Bicêtre, France), F. Parent (le Kremlin Bicêtre, France), C. Guignabert (le Kremlin Bicêtre, France), P. Herve (Le Plessis Robinson, France), G. Garcia (le Kremlin Bicêtre, France), G. Simonneau (le Kremlin Bicêtre, France), O. Sitbon (le Kremlin Bicêtre, France), M. Humbert (le Kremlin Bicêtre, France)
| |